Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-11-002641
Filing Date
2011-11-09
Accepted
2011-11-09 12:47:56
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 JINZANGHUANG TIBET PHARMACEUTICALS, INC. 10Q 2011-09-30 jinzanghuangtibet10q93011.htm 10-Q 375626
2 RULE 13A-14(A) CERTIFICATION ? CEO jinzanghuangtibetexh311.htm EX-31.1 10818
3 RULE 13A-14(A) CERTIFICATION ? CFO jinzanghuangtibetexh312.htm EX-31.2 10926
4 RULE 13A-14(B) CERTIFICATION jinzanghuangtibetexh32.htm EX-32 7312
  Complete submission text file 0001096906-11-002641.txt   1227778

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE jzhg-20110930.xml EX-101.INS 105385
6 XBRL SCHEMA jzhg-20110930.xsd EX-101.SCH 8352
7 XBRL CALCULATION jzhg-20110930_cal.xml EX-101.CAL 4766
8 XBRL DEFINITION jzhg-20110930_def.xml EX-101.DEF 41579
9 XBRL LABEL jzhg-20110930_lab.xml EX-101.LAB 75062
10 XBRL PRESENTATION jzhg-20110930_pre.xml EX-101.PRE 54122
Mailing Address HARBORSIDE FINANCIAL CENTER 2500 PLAZA V JERSEY CITY NJ 07311
Business Address HARBORSIDE FINANCIAL CENTER 2500 PLAZA V JERSEY CITY NJ 07311 201-882-3332
JINZANGHUANG TIBET PHARMACEUTICALS, INC. (Filer) CIK: 0000910832 (see all company filings)

EIN.: 262443288 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-53254 | Film No.: 111190590
SIC: 6770 Blank Checks